admin

David Mott will speak at the BioTrinity 2014 Conference, the European Bipartnering and Investment Conference on May 12-14, 2014. 

BioTrinity is the premier European Biopartnering and Investment Conference, partnering R&D companies with big pharma and more biomedical investors than any other key European partnering conference. 

The National Institutes of Health announced on Wednesday a new policy requiring that both sexes be represented among the subjects of preclinical biomedical research it finances involving animal and cell models.

More than two decades after requiring gender balance among human beings in the trials themselves, NIH leaders said they now realize that the same step should be applied to the laboratory experiments that inform those trials.

Every summer, the National Security Agency offers about 250 internships to undergraduate and graduate students interested in pursuing careers with the federal agency. If you can snag one, your career will be off to a great start.

But getting one is the hard part. There are more than 10,000 applicants every year for the internships, which span the science, technology, engineering and math fields. Richard Ledgett, deputy director of the NSA, on Wednesday told members of the BWI Business Partnership the selection process is grueling because of the high standards and required security clearances.

Johnson & Johnson’s ($JNJ) Janssen arm is planning to open another biotech incubator, this time setting its sights on South San Francisco in hopes of finding a few promising drug developers.

The new operation, dubbed Janssen Labs @South San Francisco, will be a 30,000-square-foot mix of lab and office space with room for up to 50 startups, J&J said. Mirroring Janssen’s flagship San Diego incubator, the new facility will be staffed by some of J&J’s biotech brains and provide operational support, education and business services to its guest companies. 

Richard Griffin, Director of Economic Development for the City of Frederick, and Julie Garner, Director of External Affairs, Maryland for AstraZeneca, accepted the award at the 2014 MEDA Awards Ceremony. The ceremony annually honors “standouts” in the field of economic development and the professionals who foster MEDA’s success today.

The award-winning plant, located next to the original 163,802 square foot biomanufacturing facility, provides increased capacity and has enabled AstraZeneca and MedImmune to meet the demand for new products. The company boasts world-class protein engineering and process development capabilities.

William E. (Brit) Kirwan, chancellor of the University System of Maryland and a longtime national figure in public higher education, will resign from his leadership post when a successor is named, Mr. Kirwan announced on Tuesday.

Mr. Kirwan, who is 76, has led the Maryland system for 12 years and served as president of Ohio State University from 1998 to 2002. He has been at the forefront of national conversations about reducing college costs, including athletics spending.

Mike Baader, the head of Venable’s Baltimore office, will be joining the law firm’s longtime client, Greenspring Associates, as a partner and general counsel, sources said.

The sources said Baader will stay on with the firm for several months to assist in the transition. Courtney Capute has been named to succeed Baader as head of the law firm’s Baltimore practice.

The National Institutes of Health contracting arm has launched a $20 billion governmentwide acquisition program, Nextgov reports based on solicitation documents.